Molecular detection of HCV infection in suspected liver disease patients of District Mardan, Khyber PuhktoonKhwa

Paper Details

Research Paper 01/07/2013
Views (276) Download (4)
current_issue_feature_image
publication_file

Molecular detection of HCV infection in suspected liver disease patients of District Mardan, Khyber PuhktoonKhwa

Abdul Majid, Muhammad Nasir Riaz, Tawab Khan, Junaid Ali Shah, Aurangzeb, Abdus Salam, Zakir Ullah, Muhammad Amjid Ali, Nadia Jabeen, Muhammad Asif
Int. J. Biosci.3( 7), 162-168, July 2013.
Certificate: IJB 2013 [Generate Certificate]

Abstract

Chronic hepatitis is a common cause of liver related problem due to different viruses concerned with liver, where Hepatitis C (HCV) has been documented as the major cause and lead to many complications. A total of 1500 (54% Male and 46% Female) suspected liver disease patients were selected for the study. Confirmation was carried out by ICT, ELISA and q-PCR. Age wise and gender wise and Tehsil wise distribution of the data was carried by statistical analysis. HCV RNA was detected in 438 (29.2%) samples out of total 1500 samples of suspected liver disease patients via q-PCR. Out of 438 patients, 210 (47.94%) were male and 228 (52.06 %) were female patients. In age group 41-60 years there were 210 (47.94%) HCV RNA positive patients. In age group 21-40 years it was 104 (23.74%), in >60 years it was 95 (21.68%) and in <20 years 29 (6.62%) was observed. In Tehsil wise distribution it was noted that 228 (52.05%) HCV RNA positive samples were from Tehsil Mardan and 115 (26.25%) and 95 (21.68%) from Takhtbhai and Kattlang respectively. This study concludes that the most specific, sensitive and reliable test use for detection of HCV is q-PCR. Female infectivity rate with HCV is relatively higher then male in District Mardan. Age group 41-60 years was found the most susceptible group to HCV infection in this study. Among the three Tehsil of District Mardan, the highest number of HCV infected patients was found in Tehsil Mardan with 228 (52.05%) patients.

VIEWS 1

Benani A, El-Turk J, Benjelloun S, Sekkat S, Nadifi S, Had N, Benslimane A. 1997. HCV genotypes in Morocco. Journal of Medical Virology. 52(4), 396-398. http://dx.doi.org/10.4254/wjh.v3.i1.24

Chan SW, McOmish F, Holmes EC, Dow B, Peutherer JF, Follett E. 1992. Simmonds Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. Journal General Virology. 73, 1131 – 41.

Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244, 359–362. http://dx.doi.org/1016/S0140-6736(89)91000-3

Delisse AM, Descurieux M, Rutgers T, Hondt ED, Wilde MD, Arima T. 1991. Sequence analyses of the putative structural genes of hepatitis C virus from Japenese and European origin. Hepatology Journal. 13, 20-1.

Erden S, Bryukazturk S, Langer S, Yilmaz G, Palanduz T, Badur S. 2003. A study of serological markers of hepatitis B and C viruses in Istanbul Turkey. Medical principles and practice. International Journal of Kuwait Univ Health Sci. 12(3), 184–188. http://dx.doi.org/10.1159/000070757

Gaeta B, Rapicetta M, Sardaro C, Spadaro A, Chionne F, Freni AM. 1990. Prevalence of anti-HCV antibodies in patients with chronic liver disease and its relationship to HBV and HDV infections. Infection, 18, 277-27 9.

Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K. 1991. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem. Biophys. Res. Commun. 175, 220-228.

Khokhar N, Gill ML, Malik GJ. 2004. General Seroprevalence of Hepatitis C and hepatitis B virus infections in population. Journal of College of Physicians and Surgeons Pakistan, 14, 534-536.

Kim WR. 2002. Global Epidemiology and Burden of Hepatitis C. Microbes Infect. 4, 1219-1225. http://dx.doi.org/10.1016/S1286-4579(02)01649-0

Muhammad  N,  Jan  MA.  2005.  Frequency  of hepatitis C in Buner, NWFP. J College Physicians Surg Pak. 15(1), 11–14. www.ncbi.nlm.nih.gov/pubmed/15670516

Okamoto H, Okada S, Sugiyama Y, Kurai K, Iizuka H, Machida A. 1991. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. Journal of General Virology. 72, 2697 – 2704.

Re VL, Kostman JR. 2005. Management of chronic hepatitis C. Postgraduate. Med Journal. 81, 376-382. http://dx.doi.org/10.1136/pgmj.2004.025403

Sangiovanni A, Prati GM, Fasani P, Ronchi G, Romeo R, Manini M. 2006. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Journal of Hepatology, 43, 1303-1310.

Simmonds P, Alberti A, Harvey JA, Bonino F, Daniel WB, Brechot C. 1994. A proposed system for the nomenclature of hepatitis C viral genotypes, journal of Hepatology. 19, 1321-1324. http://dx.doi.org/10.1002/hep.1840190538

Talpur AA, Ansari AG, Awan MS, Ghumro AA. 2006. Prevalence of hepatitis B and C in Surgical patients. Pakistan journal of Surgery. 22(3), 150–153.

Wilkins T, Malcolm JK, Raina D, Schade RR. 2010. Hepatitis C: diagnosis and treatment. American family physician, 81, 1351–1357.

Zein NN, Persing DH. 1996. Hepatitis C Genotypes: current trends and future implications. Mayo ClinProc. 71, 458-462. http://dx.doi.org/10.4065/71.5.458